Nephrotoxicity associated with amphotericin B deoxycholate in neonates

Pediatric Infectious Disease Journal

Volumn 28, Issue 12, 2009, Pages 1061-1063

  Le, Jennifer ^a,b   Adler Shohet, Felice C ^c   Nguyen, Christine ^b   Lieberman, Jay M ^d,e  

^a WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

^b LONG BEACH MEMORIAL MEDICAL CENTER   (United States)

^c CHILDREN S HOSPITAL OF ORANGE COUNTY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e QUEST DIAGNOSTICS NICHOLS INSTITUTE   (United States)

Author keywords

Amphotericin B; Amphotericin B deoxycholate; Infants; Neonate; Nephrotoxicity; Renal toxicity

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; CREATININE; POTASSIUM;

ARTICLE; BIRTH WEIGHT; CANDIDIASIS; CREATININE BLOOD LEVEL; GENDER; GESTATIONAL AGE; HUMAN; HYPOKALEMIA; INFANT; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; NEPHROTOXICITY; NEWBORN; NEWBORN INTENSIVE CARE; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL;

EID: 74049130173     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181af6201     Document Type: Article

References (21)

1. Fridkin SK, Kaufman D, Edwards JR, et al. Changing incidence of Candida bloodstream infections among NICU patients in the United States: 1995-2004. Pediatrics. 2006;117:1680-1687.
2. Bates D, Su L, Yu DT, et al. Mortality and costs of acute renal failure associated with amphotericin B therapy. Clin Infect Dis. 2001;32:686-693. (Pubitemid 32221925)
3. Harbarth S, Burke JP, Lloyd JF, et al. Clinical and economic outcomes of conventional amphotericin B-associated nephrotoxicity. Clin Infect Dis. 2002;35:e120-e127.
4. Ullmann AJ, Sanz MA, Tramarin A, et al. Prospective study of amphoter-icin B formulations in immunocompromised patients in 4 European countries. Clin Infect Dis. 2006;43:e29-e38.
5. Pappas PG, Kauffman CA, Andes D, et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;48:503-535.
6. Prasad PA, Coffin SE, Leckerman KH, et al. Pediatric antifungal utilization: new drugs, new trends. Pediatr Infect Dis J. 2008;27:1083-1088.
7. Baley J, Kliegman RM, Fanaroff AA. Disseminated fungal infections in very low-birth-weight infants: clinical manifestations and epidemiology. Pediatrics. 1984;73:144-152. (Pubitemid 14188494)
8. Butler K, Rench MA, Baker CJ. Amphotericin B as a single agent in the treatment of systemic candidiasis in neonates Pediatr Infect Dis J. 1990;9: 51-56.
9. Faix RG. Systemic Candida infections in infants in intensive care nurseries: high incidence of central nervous system involvement. Pediatrics. 1984; 105:616-622.
10. Fernandez M, Moylett EH, Noyola DE, et al. Candidal meningitis in neonates: a 10-year review. Clin Infect Dis. 2000;31:458-463.
11. Johnson D, Thompson TR, Green TP, et al. Systemic candidiasis in very low birth weight infants. Pediatrics. 1984;73:138-143.
12. Kingo A, Smyth JA, Waisman D. Lack of evidence of amphotericin B toxicity in very low birth weight infants treated for systemic candidiasis. Pediatr Infect Dis J. 1997;15:1002-1003.
13. Kossoff E, Buescher ES, Karlowicz MG. Candidemia in a neonatal intensive care unit: trends during fifteen years and clinical features of 111 cases. Pediatr Infect Dis J. 1998;17:504-508.
14. Holler B, Omar SA, Farid MD, et al. Effects of fluid and electrolyte management on amphotericin B-induced nephrotoxicity among extremely low birth weight infants. Pediatrics. 2004;113:e608-e616.
15. Sabra R, Branch RA. Amphotericin B nephrotoxicity. Drug Saf. 1990;5: 94-108.
16. Harbarth S, Pestotnik SL, Lloyd JF, et al. The epidemiology of nephrotox-icity associated with conventional amphotericin B therapy. Am J Med. 2001;111:528-534.
17. Makhoul I, Kassis I, Smolkin T, et al. Review of 49 neonates with acquired fungal sepsis: further characterization. Pediatrics. 2001;107:61-66.
18. Baley JE, Meyers C, Kliegman RM, et al. Pharmacokinetics, outcome of treatment, and toxic effects of amphotericin B and 5-fluorocytosine in neonates. J Pediatr. 1990;116:791-797.
19. Glick C, Graves GR, Feldman S. Neonatal fungemia and amphotericin B. South Med J. 1993;86:1368-1371.
20. Frattarelli DA, Reed MD, Giacoia GP, et al. Antifungals in systemic neonatal candidiasis. Drugs. 2004;64:949-968.
21. Turner RB, Donowitz LG, Hendley JO. Consequences of candidemia for pediatric patients. Am J Dis Child. 1985;139:178-180.